Showing results (1691-1700 of 1,712) with videos related to

Sort By:
Pageof 172
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
NPJ Precision Oncology|July 9, 2025
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancerKarl Semaan, Rashad Nawfal, John Canniff, et al.
Signal Transduction and Targeted Therapy|April 17, 2020
DNA methylation markers in the diagnosis and prognosis of common leukemiasHua Jiang, Zhiying Ou, Yingyi He, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
SNAP: Streamlined Nextflow Analysis Pipeline for Immunoprecipitation-Based Epigenomic Profiling of Circulating ChromatinZe Zhang, Paulo Da Silva Cordeiro, Surya B Chhetri, et al.
Cancer Discovery|June 10, 2018
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory FactorsTao Wang, Rong Lu, Payal Kapur, et al.
BMC Genomics|March 19, 2013
Comparative genomics of parasitic silkworm microsporidia reveal an association between genome expansion and host adaptationGuoqing Pan, Jinshan Xu, Tian Li, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung CancerDamien Vasseur, Shin Saito, Gunsagar S Gulati, et al.
Chemical Reviews|March 10, 2023
Fluids and Electrolytes under Confinement in Single-Digit NanoporesNarayana R Aluru, Fikret Aydin, Martin Z Bazant, et al.
American Journal of Ophthalmology|June 16, 2024
A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma SurgeryRon D Hays, Michelle E Tarver, Malvina Eydelman, et al.
Cell Reports. Medicine|June 19, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, et al.
Pageof 172